Почетна › Затајење срца › Јута
Kliničke studije za Затајење срца u državi Јута
22 studija za Затајење срца traži učesnike na lokacijama u državi Јута.
Gradovi u državi Јута
Zvanični tekst studije (na engleskom)
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
- University of Utah Health, Salt Lake City
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT06424288INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure Cardiogenic Shock With ImpElla 5.5 for Cardiac Recovery
- University of Utah, Salt Lake City
Тражи се учесник
Узраст од 18 до 80 · Оба пола · Ажурирано 12. 11. 2026. · NCT06965504Left vs Left Randomized Clinical Trial
- St. Mark's Hospital, Salt Lake City
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT05650658Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
- University of Utah Hospital, Salt Lake City
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT06526195Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
- Intermountain Medical Center, Murray
- University of Utah Health, Salt Lake City
Тражи се учесникФаза 3
Узраст од 18 до 85 · Оба пола · Ажурирано 4. 11. 2026. · NCT06736574A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
- Eccles Primary Children's Outpatient Services - Cardiology, Salt Lake City
Тражи се учесникФаза 3
До 18 година · Оба пола · Ажурирано 27. 10. 2026. · NCT07192952Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
- Research Site, Clearfield
- Research Site, Ogden
Тражи се учесникФаза 3
Узраст 40 и старији · Оба пола · Ажурирано 21. 10. 2026. · NCT06677060A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
- Eccles Primary Children's Outpatient Services - Cardiology, Salt Lake City
Тражи се учесникФаза 3
6 Months – 17 Years · Оба пола · Ажурирано 15. 10. 2026. · NCT07188805Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
- Research Site, Salt Lake City
Тражи се учесникФаза 3
Узраст од 18 до 130 · Оба пола · Ажурирано 13. 10. 2026. · NCT06307652Home-Based Exercise Program Using Mobile Technology After Left Ventricular Assist Device Implantation
- University of Utah Health, Salt Lake City
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 7. 10. 2026. · NCT06291922CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA)
- VA Salt Lake City Health Care System, Salt Lake City, UT, Salt Lake City
Тражи се учесник
Узраст 60 и старији · Оба пола · Ажурирано 7. 10. 2026. · NCT05996328: Vascular Function in Health and Disease
- University of Utah, Salt Lake City
Тражи се учесникФаза 1Здраве особе су добродошле
Узраст 18 и старији · Оба пола · Ажурирано 25. 9. 2026. · NCT02966665A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
- CON-10305, Layton, UT, Layton
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 10. 9. 2026. · NCT06024746A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- Intermountain Medical Center, Murray
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 18. 8. 2026. · NCT07567001LVAD Conditioning for Cardiac Recovery
- University of Utah, Salt Lake City
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 13. 8. 2026. · NCT03238690Assessing Changes in Myocardial Tissue and Blood in Patients With Advanced Heart Disease
- Intermountain Medical Center, Murray
- University of Utah Health Sciences Center, Salt Lake City
- VA Salt Lake City Health Care System, Salt Lake City
Тражи се учесникОпсервациона студија
Узраст 13 и старији · Оба пола · Ажурирано 13. 8. 2026. · NCT01099982Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia
- Primary Childrens Medical Center, Salt Lake City
Тражи се учесникФаза 3
Узраст од 2 до 11 · Оба пола · Ажурирано 24. 7. 2026. · NCT06597006Implementation and Interaction of Clinician And Patient-facing Tools Aiming to Intensify Neurohormonal Medicines for Heart Failure
- University of Utah, Salt Lake City
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 13. 7. 2026. · NCT06526988A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
- FIN-10405, Layton, UT, Layton
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 10. 7. 2026. · NCT06033950Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
- Primary Childrens Medical Center, Salt Lake City
- Primary Childrens Medical Center, Salt Lake City
Тражи се учесникФаза 3
Узраст од 6 до 11 · Оба пола · Ажурирано 15. 5. 2026. · NCT06597019Smartphone Twelve-Lead ECG Utility In ST-Elevation Myocardial Infarction II
- Intermountain Health, Murray
Тражи се учесникЗдраве особе су добродошле
Узраст 18 и старији · Оба пола · Ажурирано 9. 4. 2026. · NCT06271577Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator
- Health University of Utah, Salt Lake City
Тражи се учесникФаза 4
Узраст 18 и старији · Оба пола · Ажурирано 18. 9. 2025. · NCT06964464Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.